EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Clinical effectiveness of procalcitonin‐ or C‐reactive protein‐guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta‐analysis

Klinische Wirksamkeit von procalcitonin- oder C-reaktives-Protein-gesteuerten Protokollen zum Absetzen von Antibiotika bei erwachsenen kritisch kranken Patient:innen mit Sepsis: ein Rapid Review und eine Metaanalyse

Sonya Rafiq iD, Chunhu Shi iD, Shraboni Ghosal iD, Paul Dark iD, Tim Felton iD, Evangelos Kontopantelis iD, Jo Dumville iD

Anaesthesia · 2026-04 · 81 (4) · 556-569

DOI: 10.1111/anae.70109 ↗

Auf einen Blick

Bei kritisch kranken Erwachsenen mit Sepsis verkürzten procalcitonin-gesteuerte Protokolle die Antibiotikatherapie wahrscheinlich um 2,0 Tage. Für CRP-gesteuerte Protokolle blieb die Evidenz unklar.

Fragestellung

Wie wirksam und sicher sind procalcitonin- oder CRP-gesteuerte Protokolle zum Absetzen von Antibiotika bei kritisch kranken Erwachsenen mit Sepsis?

Methode

Rapid Systematic Review und Metaanalyse randomisierter kontrollierter Studien; systematische Suche nach Artikeln nach Januar 2005 in relevanten Datenbanken.

Ergebnisse

21 geeignete Studien. 19 RCTs mit 6.382 Patient:innen: procalcitonin-gesteuerte Protokolle reduzierten die Antibiotikatherapie um 2,0 Tage (95 %-KI -2,6 bis -1,4). 18 RCTs mit 6.238 Patient:innen: RR für Mortalität 0,95 (95 %-KI 0,83–1,07).

Einschränkungen

Die Evidenz zu CRP-gesteuerten Protokollen war sehr niedrig bis niedrig; zu diesen Ansätzen blieb die Evidenz unklar.

Schlussfolgerung der Autor:innen

Procalcitonin-gesteuerte Absetzprotokolle können bei kritisch kranken Patient:innen mit Sepsis wirksam und sicher sein, ohne erhöhtes Mortalitätsrisiko. Für CRP-gesteuerte Protokolle ist die Evidenz begrenzt.

Kernaussagen

  • Procalcitonin verkürzte die Antibiotikatherapie um 2,0 Tage
  • Mortalität: RR 0,95 (95 %-KI 0,83–1,07)
  • Für CRP-gesteuerte Protokolle blieb die Evidenz unklar

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Metaanalyse in der Zeitschrift Anaesthesia, online erschienen am 08.01.2026. Verfasst von Sonya Rafiq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, C-Reactive Protein, Procalcitonin, Sepsis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Applied Research Collaboration Greater Manchester, NIHR HealthTech Research Centre in Emergency and Acute Care, Manchester Biomedical Research Centre.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Antibiotics are a first‐line treatment for sepsis, with guidelines recommending a 7‐ to 10‐day course. Prolonged antibiotic use carries significant risks, prompting growing interest in using inflammatory biomarkers, such as procalcitonin or C‐reactive protein, to guide clinical decision‐making on the duration of antibiotic therapy in patients who are critically ill. This rapid systematic review aims to assess the effectiveness and safety of using procalcitonin‐ or C‐reactive protein‐guided protocols for antibiotic discontinuation in patients who are critically ill with sepsis.

Methods

We conducted systematic searches for articles published after January 2005 in relevant databases. Eligible studies included randomised controlled trials comparing procalcitonin‐ or C‐reactive protein‐guided protocols for antibiotic discontinuation with standard care, or with each other. Primary outcomes were duration of antibiotic therapy and mortality. Secondary outcomes included infection recurrences; secondary infections or superinfections; and the duration of intensive care and hospital stays.

Results

We identified 21 eligible studies. Moderate certainty evidence from 19 trials, involving 6382 patients, indicated that procalcitonin‐guided protocols probably reduced antibiotic therapy by, on average, 2.0 days (95%CI ‐2.6 to ‐1.4) compared with standard care. Moderate certainty evidence from 18 trials, involving 6238 patients, suggested an average 5% reduction in mortality risk when using procalcitonin‐guided protocols compared with standard care (risk ratio 0.95, 95%CI 0.83–1.07). The evidence regarding C‐reactive protein‐guided protocols versus standard care approaches remained unclear, with very low to low certainty evidence available.

Discussion

Combining relevant trials suggests that procalcitonin‐guided discontinuation protocols may be both safe and effective for patients who are critically ill with sepsis, with no increased risk in mortality. In contrast, the evidence supporting C‐reactive protein‐guided protocols is limited. These findings underscore the potential importance of utilising procalcitonin to inform antimicrobial stewardship practices, particularly in critical care settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsC-Reactive ProteinProcalcitoninSepsisAdultHumansBiomarkersCritical IllnessTreatment Outcome

Stichwörter der Autor:innen

C‐reactive proteinanti‐bacterial drugsbiomarkersprocalcitoninsepsis

Substanzen

Anti-Bacterial AgentsBiomarkersC-Reactive ProteinProcalcitonin

Autor:innen und Institutionen

  • Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK.
  • Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, UK.
  • Critical Care Unit, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
  • Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

ORCID-Profile: Sonya Rafiq, Chunhu Shi, Shraboni Ghosal, Paul Dark, Tim Felton, Evangelos Kontopantelis, Jo Dumville

Förderung

  • NIHR Applied Research Collaboration Greater Manchester
  • NIHR HealthTech Research Centre in Emergency and Acute Care
  • Manchester Biomedical Research Centre

Zitieren

APA

Rafiq, S., Shi, C., Ghosal, S., Dark, P., Felton, T., Kontopantelis, E., & Dumville, J. (2026). Clinical effectiveness of procalcitonin‐ or C‐reactive protein‐guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta‐analysis. Anaesthesia, 81(4), 556-569. https://doi.org/10.1111/anae.70109

Vancouver

Rafiq S, Shi C, Ghosal S, Dark P, Felton T, Kontopantelis E, et al. Clinical effectiveness of procalcitonin‐ or C‐reactive protein‐guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta‐analysis. Anaesthesia. 2026;81(4):556-569. doi:10.1111/anae.70109

BibTeX
@article{Rafiq2026,
  author = {Rafiq, Sonya and Shi, Chunhu and Ghosal, Shraboni and Dark, Paul and Felton, Tim and Kontopantelis, Evangelos and Dumville, Jo},
  title = {Clinical effectiveness of procalcitonin‐ or C‐reactive protein‐guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta‐analysis},
  journal = {Anaesthesia},
  year = {2026},
  volume = {81},
  number = {4},
  pages = {556--569},
  doi = {10.1111/anae.70109}
}
Kostenlos starten →